{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:27:20Z","timestamp":1785403640167,"version":"3.56.0"},"reference-count":18,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14226","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T12:05:02Z","timestamp":1704888302000},"source":"Crossref","is-referenced-by-count":1,"title":["Combination treatment with paclitaxel, carboplatin and cetuximab in maxillary sinus cancer: A case report"],"prefix":"10.3892","volume":"27","author":[{"given":"Masahiro","family":"Morimoto","sequence":"first","affiliation":[{"name":"Department of Oral Diagnosis and Medicine, Hokkaido University Faculty of Dental Medicine, Sapporo, Hokkaido 060\u20118586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Dentistry and Oral Surgery, Hokuto Hospital, Obihiro, Hokkaido 080\u20110833, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Dentistry and Oral Surgery, Hokuto Hospital, Obihiro, Hokkaido 080\u20110833, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujiroh","family":"Makino","sequence":"additional","affiliation":[{"name":"Department of Dentistry and Oral Surgery, Hokuto Hospital, Obihiro, Hokkaido 080\u20110833, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"key20240216093812_b1-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1002\/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E","article-title":"Nasal and paranasal sinus carcinoma: Are we making progress?: A series of 220 patients and a systematic review","volume":"92","author":"Dulguerov","year":"2001","journal-title":"Cancer"},{"key":"key20240216093812_b2-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.jcms.2017.10.003","article-title":"Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors","volume":"45","author":"Ono","year":"2017","journal-title":"J Craniomaxillofac Surg"},{"key":"key20240216093812_b3-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00432-002-0338-1","article-title":"Elective neck irradiation in locally advanced squamous cell carcinoma of the maxillary sinus: A review","volume":"128","author":"Jeremic","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20240216093812_b4-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0714.1985.tb00462.x","article-title":"Maxillary sinus cancer: A study of 33 cases","volume":"14","author":"Mundy","year":"1985","journal-title":"J Oral Pathol Med"},{"key":"key20240216093812_b5-ol-27-3-14226","first-page":"e14118","article-title":"Sinonasal tract malignancies: Prognostic factors and surgery outcomes","volume":"15","author":"Cengiz","year":"2013","journal-title":"Iran Red Crescent Med J"},{"key":"key20240216093812_b6-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4081\/rt.2009.e36","article-title":"Treatment outcome of maxillary sinus cancer","volume":"1","author":"Won","year":"2009","journal-title":"Rare Tumors"},{"key":"key20240216093812_b7-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/lary.29697","article-title":"Maxillary sinus floor infiltration: Results from a series of 118 maxillary sinus cancers","volume":"132","author":"Arosio","year":"2022","journal-title":"Laryngoscope"},{"key":"key20240216093812_b8-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1002\/cncr.24515","article-title":"Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: A single institution experience","volume":"115","author":"Homma","year":"2009","journal-title":"Cancer"},{"key":"key20240216093812_b9-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.2009.23.0425","article-title":"Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trial","volume":"28","author":"Kies","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20240216093812_b10-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/annonc\/mdy040","article-title":"Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)","volume":"29","author":"Tahara","year":"2018","journal-title":"Ann Oncol"},{"key":"key20240216093812_b11-ol-27-3-14226","first-page":"1330","article-title":"Feasibility of combination of paclitaxel, carboplatin, and cetuximab as induction chemotherapy for advanced head and neck squamous cell carcinoma","volume":"3","author":"Takenaka","year":"2019","journal-title":"Clin Oncol"},{"key":"key20240216093812_b12-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"key20240216093812_b13-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/annonc\/mdy549","article-title":"Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma","volume":"30","author":"Haddad","year":"2019","journal-title":"Ann Oncol"},{"key":"key20240216093812_b14-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/cam4.2852","article-title":"A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck","volume":"9","author":"Enokida","year":"2020","journal-title":"Cancer Med"},{"key":"key20240216093812_b15-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3892\/etm.2013.948","article-title":"Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck","volume":"5","author":"Bauman","year":"2013","journal-title":"Exp Ther Med"},{"key":"key20240216093812_b16-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1200\/JCO.2021.39.15_suppl.6042","article-title":"Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer in elderly or frail patients","volume":"39","author":"Forman","year":"2021","journal-title":"J Clin Oncol"},{"key":"key20240216093812_b17-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1007\/s10147-020-01742-6","article-title":"Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil","volume":"25","author":"Shirasu","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"key20240216093812_b18-ol-27-3-14226","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1200\/JCO.2012.42.3988","article-title":"Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: The TREMPLIN randomized phase II study","volume":"31","author":"Lefebvre","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T07:38:19Z","timestamp":1708069099000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,1,10]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14226","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"article-number":"93"}}